Ketamine for Chronic Pain Conditions

Ketamine, first synthesized in 1962 and FDA-approved in 1970, is a dissociative anesthetic and analgosedative, meaning it provides both pain relief and sedation.

While traditionally used by anesthesiologists, ketamine’s role in treating chronic pain has expanded in recent years, particularly as a response to the opioid epidemic.

According to the Institute of Medicine, 1 in 3 people in the U.S. are affected by chronic pain, underscoring the need for effective alternatives to opioid therapy.

How Does Ketamine Relieve Pain?

Pain is a complex experience that involves both physical and psychological components. Chronic pain often leads to central sensitization, where pain signals are amplified in the spinal cord.

Ketamine works by blocking NMDA receptors, which helps prevent the amplification of these pain signals, effectively resetting the pain pathways in the brain and providing relief.

Ketamine presents a low addiction potential when compared to opioids, even more so when administered in a controlled environment with guidance from healthcare professionals

Ketamine for Chronic Pain Conditions

Ketamine, first synthesized in 1962 and FDA-approved in 1970, is a dissociative anesthetic and analgosedative, meaning it provides both pain relief and sedation. While traditionally used by anesthesiologists, ketamine’s role in treating chronic pain has expanded in recent years, particularly as a response to the opioid epidemic.

According to the Institute of Medicine, 1 in 3 people in the U.S. are affected by chronic pain, underscoring the need for effective alternatives to opioid therapy.

How Does Ketamine Relieve Pain?

Pain is a complex experience that involves both physical and psychological components. Chronic pain often leads to central sensitization, where pain signals are amplified in the spinal cord. Ketamine works by blocking NMDA receptors, which helps prevent the amplification of these pain signals, effectively resetting the pain pathways in the brain and providing relief.

Ketamine presents a low addiction potential when compared to opioids, even more so when administered in a controlled environment with guidance from healthcare professionals

Ketamine:
A Safe, Effective Alternative

With proper oversight, ketamine can be a transformative treatment for select patients struggling with chronic pain. It offers a patient-centered approach to pain relief, improving quality of life without the risk of opioid dependence.

Interested in learning more?

3 Ketamine A Safe, Effective Alternative

Ketamine:
A Safe, Effective Alternative

With proper oversight, ketamine can be a transformative treatment for select patients struggling with chronic pain. It offers a patient-centered approach to pain relief, improving quality of life without the risk of opioid dependence.

Interested in learning more?

3 Ketamine A Safe, Effective Alternative

Ketamine Works by blocking NMDA receptors

For Chronic Pain

Check IconInterrupt pain signals in the central nervous system.

Check IconReduces central sensitization, a key driver of chronic pain, by calming overactive nerve responses.

Check IconDelivers rapid pain relief with low addiction risk, offering a safer alternative to opioids.

Ketamine Works by blocking NMDA receptors

For Chronic Pain

Check IconInterrupt pain signals in the central nervous system.

Check IconReduces central sensitization, a key driver of chronic pain, by calming overactive nerve responses.

Check IconDelivers rapid pain relief with low addiction risk, offering a safer alternative to opioids.

Our Core Services

Ketamine-Infusion-Therapy1

Ketamine Infusion Therapy

  • Ketamine infusion therapy involves the administration of ketamine in a controlled medical setting.
  • We use a tailored approach to treatment depending on your condition and medical history. See FAQs or contact us for more information
5 Our Core Services KAP

Ketamine-Assisted Psychotherapy (KAP)

  • Combining ketamine treatment with psychotherapy has the potential to significantly enhance its benefits for mental health and chronic pain conditions compared to ketamine alone.

Why Choose Ketamine Infusion Therapy?

Compared to other routes of ketamine administration, IV ketamine therapy offers fast-acting relief, with the added benefit of predictable, controlled delivery and the ability to adjust dosing rapidly and easily.

Check Icon IV Infusion 
Maximum bioavailability for full therapeutic effect.

Check Icon Intramuscular Injection 
While rapidly absorbed with high bioavailability, can result in a more intense, less gradual experience, making precise dosing more challenging.

Check Icon Nasal Spray (Spravato)® 
Only about 50% bioavailability, leading to less predictable effects.

6 Why Choose Ketamine Infusion Therapy

REFERENCES

Orhurhu V, Orhurhu MS, Bhatia A, Cohen SP. Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Anesth Analg. 2019 Jul;129(1):241-254. doi: 10.1213/ANE.0000000000004185. PMID: 31082965.
Noppers, I., Niesters, M., Aarts, L., Smith, T., Sarton, E., & Dahan, A. (2011). Ketamine for the treatment of chronic non-cancer pain. Pain, 152(3), 566–575. https://pubmed.ncbi.nlm.nih.gov/21482474/


Jackson, K., Ashby, M. A., Martin, P., Murphy, D., & Clark, R. J. (2020). Efficacy and safety of ketamine in cancer pain: A systematic review of randomized controlled trials. Pain Medicine, 14(10), 1505–1513. https://academic.oup.com/painmedicine/article/14/10/1505/1833346

Bell, R. F., Eccleston, C., Kalso, E. A., & Carr, D. B. (2013). Ketamine for neuropathic pain: A systematic review. The Journal of Pain, 14(9), 864–874. https://doi.org/10.1016/j.jpain.2013.06.002


American Society of Regional Anesthesia. (2022, July 29). Ketamine infusion therapy and its role in chronic pain. ASRA Newsletter. https://asra.com/news-publications/asra-newsletter/newsletter-item/asra-news/2022/07/29/ketamine-infusion-therapy-and-its-role-in-chronic-pain


Campbell R, Lobo MK. A short burst of reward curbs the addictiveness of ketamine. Nature. 2022 Aug;608(7922):271-272. doi: 10.1038/d41586-022-01948-w. PMID: 35896660; PMCID: PMC10342185.